Matthew R Henn
See Remarks at Seres Therapeutics, Inc. (MCRB)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $23K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 18SEC | MCRBSeres Therapeutics, Inc. | Sell Plan | 817,995 held (−1%) | $4.55 | $369 | -45.9% |
| May 19SEC | MCRBSeres Therapeutics, Inc. | Sell Plan | 777,838 held (−1%) | $7.53 | $580 | -67.3% |
| Feb 18SEC | MCRBSeres Therapeutics, Inc. | Sell Plan | 897,677 held (−1%) | $8.47 | $754 | -71.0% |
| Nov 18SEC | MCRBSeres Therapeutics, Inc. | Sell Plan | 1,2577,527 held (−14%) | $17.30 | $22K | -85.8% |
- Sell
See Remarks Matthew R Henn sold $369 of MCRB at $4.55 — pre-scheduled 10b5-1 plan sale.
- Sell
See Remarks Matthew R Henn sold $580 of MCRB at $7.53 — pre-scheduled 10b5-1 plan sale.
- Sell
See Remarks Matthew R Henn sold $754 of MCRB at $8.47 — pre-scheduled 10b5-1 plan sale.
- Sell
See Remarks Matthew R Henn sold $22K of MCRB at $17.30 — pre-scheduled 10b5-1 plan sale.